Michael Gelband’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.64M Buy
+67,672
New +$2.63M 0.02% 719
2023
Q1
Sell
-102,574
Closed -$734K 1949
2022
Q4
$734K Sell
102,574
-168,837
-62% -$1.21M 0.01% 1055
2022
Q3
$2.1M Buy
271,411
+252,480
+1,334% +$2.45M 0.03% 782
2022
Q2
$145K Sell
18,931
-62,682
-77% -$440K ﹤0.01% 1704
2022
Q1
$630K Buy
+81,613
New +$3.18M 0.01% 1401
2021
Q1
Sell
-4,911
Closed -$721K 2361
2020
Q4
$721K Sell
4,911
-6,674
-58% -$744K 0.01% 1038
2020
Q3
$686K Buy
+11,585
New +$581K 0.01% 848

Other funds holding KOD

Michael Gelband's KOD Position: Q2 2026 in Review

Michael Gelband opened a new position in Kodiak Sciences (KOD) in Q2 2026: 67,672 shares worth $2.64M. The stake represents 0.02% of the portfolio and ranks #719 among its holdings. This is a return to the name: Michael Gelband previously reported a position in KOD as recently as Q4 2022.

Michael Gelband first reported a position in KOD in Q3 2020 and has held it in 7 quarters since. 198 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Michael Gelband held 67,672 shares of Kodiak Sciences worth $2.64M as of Q2 2026.
  • Kodiak Sciences was a new Michael Gelband position in Q2 2026.
  • Kodiak Sciences made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #719 holding.
  • Michael Gelband first reported a position in Kodiak Sciences in Q3 2020 and has held it in 7 quarters since.
  • 198 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.